We are excited to announce a new collaboration with CCRM Nordic, the Nordic centre for advanced therapy medicinal products (ATMPs).
By combining Cellectricon’s deep expertise in neuroscience and stem cell technologies with CCRM Nordic’s end-to-end capabilities in ATMP process development and manufacturing capabilities, as well as expertise in stem cells, the partnership aims to establish scalable, reproducible manufacturing approaches for complex cell models used in early drug discovery, safety testing and therapeutic development.
If you are curious to learn more about our stem cell-based in vitro models and how we can apply these to support your drug discovery projects, please get in touch.